A Startup Says It Grew Human Sperm in a Lab—and Used It to Make Embryos
Biotech startup grows human sperm from stem cells in lab

“Paterna Biosciences says it has determined the set of instructions needed to turn sperm-making stem cells into "normal, mature" sperm.”
The Weekly Silicon take
If the claim holds, the work addresses a long-standing barrier in reproductive biology: getting stem cells to complete the path to mature, functional sperm outside the body. Producing embryos from that sperm is the company's proof of function. The result comes from the company itself, so it sits at the claim stage until outside scientists can examine the method. Men whose bodies produce no sperm are the group with the most at stake, along with fertility clinics and the researchers working on lab-grown gametes. Regulators and ethics bodies are also implicated, because embryo creation from lab-derived cells raises questions that existing fertility rules may not cover. Investors in the startup and its competitors will read the result as a test of whether this field can become a clinical business. The key signal is peer-reviewed publication with full methods, followed by independent labs reproducing the result. Look for data on the genetic and epigenetic quality of the sperm and the resulting embryos. Regulator statements, clinical trial filings and new funding rounds would show whether the work is moving toward patients or staying in the lab.
AI score breakdown
A composite of 7.15/10 put this story at #4 for Thursday, April 23, 2026, driven mostly by policy & geopolitics (9/10) and technology breakthrough (8/10).
Composite is the weighted sum of the five dimensions. How scoring works →